Selected research
Industry Research
SNP Microarray Testing and Analysis Industry Research Report 2026
Market perspective
The global SNP Microarray Testing and Analysis market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the SNP Microarray Testing and Analysis market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the SNP Microarray Testing and Analysis market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the SNP Microarray Testing and Analysis market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of SNP Microarray Testing and Analysis include Thermo Fisher Scientific, Illumina, Agilent, Roche, Bio-Rad, CD Genomics, Ambry Genetics, Labcorp and Allele Diagnostics, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global SNP Microarray Testing and Analysis market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to SNP Microarray Testing and Analysis.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
SNP Microarray Testing and Analysis Market by Company
Thermo Fisher Scientific
Illumina
Agilent
Roche
Bio-Rad
CD Genomics
Ambry Genetics
Labcorp
Allele Diagnostics
Sonic Genetics
Invitae
Genetics Generation Advancement (GGA)
Quest Diagnostics
CapitalBio
HNL Lab Medicine
Psomagen
VCGS
Genetics Associates
SNP Microarray Testing and Analysis Segment by Type
Whole Genome SNP Microarrays
Custom SNP Microarrays
SNP Microarray Testing and Analysis Segment by Application
Pharmaceuticals and Pharmacogenomics
Diagnostic Research
Agricultural Biotechnology
Other
SNP Microarray Testing and Analysis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global SNP Microarray Testing and Analysis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of SNP Microarray Testing and Analysis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of SNP Microarray Testing and Analysis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of SNP Microarray Testing and Analysis companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Genome SNP Microarrays
- Custom SNP Microarrays
Applications
- Pharmaceuticals and Pharmacogenomics
- Diagnostic Research
- Agricultural Biotechnology
- Other
Companies covered
- Thermo Fisher Scientific
- Illumina
- Agilent
- Roche
- Bio-Rad
- CD Genomics
- Ambry Genetics
- Labcorp
- Allele Diagnostics
- Sonic Genetics
- Invitae
- Genetics Generation Advancement (GGA)
- Quest Diagnostics
- CapitalBio
- HNL Lab Medicine
- Psomagen
- VCGS
- Genetics Associates
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 SNP Microarray Testing and Analysis by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Whole Genome SNP Microarrays
- 2.2.3 Custom SNP Microarrays
- 2.3 SNP Microarray Testing and Analysis by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Pharmaceuticals and Pharmacogenomics
- 2.3.3 Diagnostic Research
- 2.3.4 Agricultural Biotechnology
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 SNP Microarray Testing and Analysis Breakdown Data by Type
- 3.1 Global SNP Microarray Testing and Analysis Historic Market Size by Type (2021-2026)
- 3.2 Global SNP Microarray Testing and Analysis Forecasted Market Size by Type (2027-2032)
4 SNP Microarray Testing and Analysis Breakdown Data by Application
- 4.1 Global SNP Microarray Testing and Analysis Historic Market Size by Application (2021-2026)
- 4.2 Global SNP Microarray Testing and Analysis Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global SNP Microarray Testing and Analysis Market Perspective (2021-2032)
- 5.2 Global SNP Microarray Testing and Analysis Growth Trends by Region
- 5.2.1 Global SNP Microarray Testing and Analysis Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 SNP Microarray Testing and Analysis Historic Market Size by Region (2021-2026)
- 5.2.3 SNP Microarray Testing and Analysis Forecasted Market Size by Region (2027-2032)
- 5.3 SNP Microarray Testing and Analysis Market Dynamics
- 5.3.1 SNP Microarray Testing and Analysis Industry Trends
- 5.3.2 SNP Microarray Testing and Analysis Market Drivers
- 5.3.3 SNP Microarray Testing and Analysis Market Challenges
- 5.3.4 SNP Microarray Testing and Analysis Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top SNP Microarray Testing and Analysis Players by Revenue
- 6.1.1 Global Top SNP Microarray Testing and Analysis Players by Revenue (2021-2026)
- 6.1.2 Global SNP Microarray Testing and Analysis Revenue Market Share by Players (2021-2026)
- 6.2 Global SNP Microarray Testing and Analysis Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of SNP Microarray Testing and Analysis Head Office and Area Served
- 6.4 Global SNP Microarray Testing and Analysis Players, Product Type & Application
- 6.5 Global SNP Microarray Testing and Analysis Manufacturers Established Date
- 6.6 Global SNP Microarray Testing and Analysis Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America SNP Microarray Testing and Analysis Market Size (2021-2032)
- 7.2 North America SNP Microarray Testing and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America SNP Microarray Testing and Analysis Market Size by Country (2021-2026)
- 7.4 North America SNP Microarray Testing and Analysis Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe SNP Microarray Testing and Analysis Market Size (2021-2032)
- 8.2 Europe SNP Microarray Testing and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe SNP Microarray Testing and Analysis Market Size by Country (2021-2026)
- 8.4 Europe SNP Microarray Testing and Analysis Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific SNP Microarray Testing and Analysis Market Size (2021-2032)
- 9.2 Asia-Pacific SNP Microarray Testing and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific SNP Microarray Testing and Analysis Market Size by Country (2021-2026)
- 9.4 Asia-Pacific SNP Microarray Testing and Analysis Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America SNP Microarray Testing and Analysis Market Size (2021-2032)
- 10.2 South America SNP Microarray Testing and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America SNP Microarray Testing and Analysis Market Size by Country (2021-2026)
- 10.4 South America SNP Microarray Testing and Analysis Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa SNP Microarray Testing and Analysis Market Size (2021-2032)
- 11.2 Middle East & Africa SNP Microarray Testing and Analysis Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa SNP Microarray Testing and Analysis Market Size by Country (2021-2026)
- 11.4 Middle East & Africa SNP Microarray Testing and Analysis Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Thermo Fisher Scientific
- 12.1.1 Thermo Fisher Scientific Company Information
- 12.1.2 Thermo Fisher Scientific Business Overview
- 12.1.3 Thermo Fisher Scientific Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.1.4 Thermo Fisher Scientific SNP Microarray Testing and Analysis Product Portfolio
- 12.1.5 Thermo Fisher Scientific Recent Developments
- 12.2 Illumina
- 12.2.1 Illumina Company Information
- 12.2.2 Illumina Business Overview
- 12.2.3 Illumina Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.2.4 Illumina SNP Microarray Testing and Analysis Product Portfolio
- 12.2.5 Illumina Recent Developments
- 12.3 Agilent
- 12.3.1 Agilent Company Information
- 12.3.2 Agilent Business Overview
- 12.3.3 Agilent Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.3.4 Agilent SNP Microarray Testing and Analysis Product Portfolio
- 12.3.5 Agilent Recent Developments
- 12.4 Roche
- 12.4.1 Roche Company Information
- 12.4.2 Roche Business Overview
- 12.4.3 Roche Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.4.4 Roche SNP Microarray Testing and Analysis Product Portfolio
- 12.4.5 Roche Recent Developments
- 12.5 Bio-Rad
- 12.5.1 Bio-Rad Company Information
- 12.5.2 Bio-Rad Business Overview
- 12.5.3 Bio-Rad Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.5.4 Bio-Rad SNP Microarray Testing and Analysis Product Portfolio
- 12.5.5 Bio-Rad Recent Developments
- 12.6 CD Genomics
- 12.6.1 CD Genomics Company Information
- 12.6.2 CD Genomics Business Overview
- 12.6.3 CD Genomics Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.6.4 CD Genomics SNP Microarray Testing and Analysis Product Portfolio
- 12.6.5 CD Genomics Recent Developments
- 12.7 Ambry Genetics
- 12.7.1 Ambry Genetics Company Information
- 12.7.2 Ambry Genetics Business Overview
- 12.7.3 Ambry Genetics Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.7.4 Ambry Genetics SNP Microarray Testing and Analysis Product Portfolio
- 12.7.5 Ambry Genetics Recent Developments
- 12.8 Labcorp
- 12.8.1 Labcorp Company Information
- 12.8.2 Labcorp Business Overview
- 12.8.3 Labcorp Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.8.4 Labcorp SNP Microarray Testing and Analysis Product Portfolio
- 12.8.5 Labcorp Recent Developments
- 12.9 Allele Diagnostics
- 12.9.1 Allele Diagnostics Company Information
- 12.9.2 Allele Diagnostics Business Overview
- 12.9.3 Allele Diagnostics Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.9.4 Allele Diagnostics SNP Microarray Testing and Analysis Product Portfolio
- 12.9.5 Allele Diagnostics Recent Developments
- 12.10 Sonic Genetics
- 12.10.1 Sonic Genetics Company Information
- 12.10.2 Sonic Genetics Business Overview
- 12.10.3 Sonic Genetics Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.10.4 Sonic Genetics SNP Microarray Testing and Analysis Product Portfolio
- 12.10.5 Sonic Genetics Recent Developments
- 12.11 Invitae
- 12.11.1 Invitae Company Information
- 12.11.2 Invitae Business Overview
- 12.11.3 Invitae Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.11.4 Invitae SNP Microarray Testing and Analysis Product Portfolio
- 12.11.5 Invitae Recent Developments
- 12.12 Genetics Generation Advancement (GGA)
- 12.12.1 Genetics Generation Advancement (GGA) Company Information
- 12.12.2 Genetics Generation Advancement (GGA) Business Overview
- 12.12.3 Genetics Generation Advancement (GGA) Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.12.4 Genetics Generation Advancement (GGA) SNP Microarray Testing and Analysis Product Portfolio
- 12.12.5 Genetics Generation Advancement (GGA) Recent Developments
- 12.13 Quest Diagnostics
- 12.13.1 Quest Diagnostics Company Information
- 12.13.2 Quest Diagnostics Business Overview
- 12.13.3 Quest Diagnostics Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.13.4 Quest Diagnostics SNP Microarray Testing and Analysis Product Portfolio
- 12.13.5 Quest Diagnostics Recent Developments
- 12.14 CapitalBio
- 12.14.1 CapitalBio Company Information
- 12.14.2 CapitalBio Business Overview
- 12.14.3 CapitalBio Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.14.4 CapitalBio SNP Microarray Testing and Analysis Product Portfolio
- 12.14.5 CapitalBio Recent Developments
- 12.15 HNL Lab Medicine
- 12.15.1 HNL Lab Medicine Company Information
- 12.15.2 HNL Lab Medicine Business Overview
- 12.15.3 HNL Lab Medicine Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.15.4 HNL Lab Medicine SNP Microarray Testing and Analysis Product Portfolio
- 12.15.5 HNL Lab Medicine Recent Developments
- 12.16 Psomagen
- 12.16.1 Psomagen Company Information
- 12.16.2 Psomagen Business Overview
- 12.16.3 Psomagen Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.16.4 Psomagen SNP Microarray Testing and Analysis Product Portfolio
- 12.16.5 Psomagen Recent Developments
- 12.17 VCGS
- 12.17.1 VCGS Company Information
- 12.17.2 VCGS Business Overview
- 12.17.3 VCGS Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.17.4 VCGS SNP Microarray Testing and Analysis Product Portfolio
- 12.17.5 VCGS Recent Developments
- 12.18 Genetics Associates
- 12.18.1 Genetics Associates Company Information
- 12.18.2 Genetics Associates Business Overview
- 12.18.3 Genetics Associates Revenue in SNP Microarray Testing and Analysis Business (2021-2026)
- 12.18.4 Genetics Associates SNP Microarray Testing and Analysis Product Portfolio
- 12.18.5 Genetics Associates Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst